Markku J. Savolainen
Oulu University Hospital(FI)University of Oulu(FI)
Publications by Year
Research Areas
Diabetes, Cardiovascular Risks, and Lipoproteins, Metabolomics and Mass Spectrometry Studies, Liver Disease Diagnosis and Treatment, Alcohol Consumption and Health Effects, Lipoproteins and Cardiovascular Health
Most-Cited Works
- → 3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial(2017)824 cited
- → Genome-wide study for circulating metabolites identifies 62 loci and reveals novel systemic effects of LPA(2016)818 cited
- → Safety, tolerability and sustained weight loss over 2 years with the once-daily human GLP-1 analog, liraglutide(2011)742 cited
- → High-throughput serum NMR metabonomics for cost-effective holistic studies on systemic metabolism(2009)638 cited
- → Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma(2011)591 cited
- → Genome-wide association study identifies multiple loci influencing human serum metabolite levels(2012)580 cited